Product Information

PITAVASTATIN 2 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.9690 per EA under NDC 65162003009. Its NADAC has been published 80 times since May 7, 2025.

FDA first approved this application on Aug 20, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PITAVASTATIN 2 MG TABLET

Pitavastatin
$0.9690per EA

Strength

2 mg/1

NDC

65162003009

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PITAVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA205961

FDA Approved

8/20/2024

TE Code

AB

On Market Since

8/21/2024

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PITAVASTATIN 2 MG TABLET has been published 80 times since May 7, 2025, and over the history we have for it it has declined 36.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9690 per EA
All-time high$1.5515 (Jul 16, 2025)
All-time low$0.9543 (Sep 23, 2026)
52-week high$1.3654
52-week low$0.9543
Median price$1.3211
Average price$1.2873
Largest weekly change-10.2% (Jul 22, 2026)
Weeks tracked80
Tracking sinceMay 7, 2025

Price History

1W

0.0%

1M

+1.5%

3M

-1.8%

6M

-20.4%

1Y

-30.4%

3Y

N/A

5Y

N/A

All

-36.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PITAVASTATIN 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 2 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.9690 per EA (NDC 65162003009), effective Nov 11, 2026.

How has the price of PITAVASTATIN 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for PITAVASTATIN 2 MG TABLET has declined 36.6%. It has been tracked across 80 weekly CMS publications since May 7, 2025.

What are the highest and lowest recorded NADAC prices for PITAVASTATIN 2 MG TABLET?

Since May 7, 2025, the NADAC for PITAVASTATIN 2 MG TABLET has ranged from a low of $0.9543 (Sep 23, 2026) to a high of $1.5515 (Jul 16, 2025), with a median of $1.3211 per EA.

Are there cheaper alternatives to PITAVASTATIN 2 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PITAVASTATIN 2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PITAVASTATIN 2 MG TABLET?

PITAVASTATIN 2 MG TABLET (NDC 65162003009) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.